Literature DB >> 27231307

When to consider a diagnosis of MODY at the presentation of diabetes: aetiology matters for correct management.

Agata Juszczak1, Rebecca Pryse2, Andrew Schuman3, Katharine R Owen4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27231307      PMCID： PMC4871313          DOI： 10.3399/bjgp16X685537

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  7 in total

Review 1.  Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation.

Authors:  R Murphy; D M Turnbull; M Walker; A T Hattersley
Journal:  Diabet Med       Date:  2008-02-18       Impact factor: 4.359

2.  Maturity-onset diabetes of the young (MODY): how many cases are we missing?

Authors:  B M Shields; S Hicks; M H Shepherd; K Colclough; A T Hattersley; S Ellard
Journal:  Diabetologia       Date:  2010-05-25       Impact factor: 10.122

3.  Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection.

Authors:  E R Pearson; S Pruhova; C J Tack; A Johansen; H A J Castleden; P J Lumb; A S Wierzbicki; P M Clark; J Lebl; O Pedersen; S Ellard; T Hansen; A T Hattersley
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

Review 4.  Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5.

Authors:  Yi-Zhi Chen; Qing Gao; Xue-Zhi Zhao; Ying-Zhang Chen; Craig L Bennett; Xi-Shan Xiong; Chang-Lin Mei; Yong-Quan Shi; Xiang-Mei Chen
Journal:  Chin Med J (Engl)       Date:  2010-11       Impact factor: 2.628

5.  A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.

Authors:  G Thanabalasingham; N Shah; M Vaxillaire; T Hansen; T Tuomi; D Gašperíková; M Szopa; E Tjora; T J James; P Kokko; F Loiseleur; E Andersson; S Gaget; B Isomaa; N Nowak; H Raeder; J Stanik; P R Njolstad; M T Malecki; I Klimes; L Groop; O Pedersen; P Froguel; M I McCarthy; A L Gloyn; K R Owen
Journal:  Diabetologia       Date:  2011-08-04       Impact factor: 10.122

6.  Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.

Authors:  Gaya Thanabalasingham; Aparna Pal; Mary P Selwood; Christina Dudley; Karen Fisher; Polly J Bingley; Sian Ellard; Andrew J Farmer; Mark I McCarthy; Katharine R Owen
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112

7.  Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia.

Authors:  Anna M Steele; Beverley M Shields; Kirsty J Wensley; Kevin Colclough; Sian Ellard; Andrew T Hattersley
Journal:  JAMA       Date:  2014-01-15       Impact factor: 56.272
  7 in total
  7 in total

1.  Alterations of glycaemia, insulin resistance and body mass index within the C-peptide optimal range in non-diabetic patients.

Authors:  Vladimir Kron; Miroslav Verner; Pavel Smetana; Jana Janoutova; Vladimir Janout; Karel Martinik
Journal:  J Appl Biomed       Date:  2020-12-08       Impact factor: 1.797

Review 2.  Meta-analysis of HNF1A-MODY3 variants among human population.

Authors:  Rachna Behl; Nishtha Malhotra; Vinay Joshi; Shruti Poojary; Sanniya Middha; Shalini Gupta; Arinola B Olaonipekun; Ikechukwu Okoye; Bhushan Wagh; Dibyendu Biswas; Chukwuemelie Aginah; Bhavya Saini; Chinaza Nwanya; Sopuluchukwu Ugwu; Modupe M Anthony; Xuanyu S Fang; Ogunfile Foluso; Abdulrahman Tudu Ibrahim
Journal:  J Diabetes Metab Disord       Date:  2022-02-02

Review 3.  The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY).

Authors:  Ken Munene Nkonge; Dennis Karani Nkonge; Teresa Njeri Nkonge
Journal:  Clin Diabetes Endocrinol       Date:  2020-11-04

4.  DPARD: rationale, design and initial results from the Dutch national diabetes registry.

Authors:  Jessica C G Bak; Dick Mul; Erik H Serné; Harold W de Valk; Theo C J Sas; Petronella H Geelhoed-Duijvestijn; Mark H H Kramer; Max Nieuwdorp; Carianne L Verheugt
Journal:  BMC Endocr Disord       Date:  2021-06-16       Impact factor: 2.763

Review 5.  Genetics and Pathophysiology of Maturity-onset Diabetes of the Young (MODY): A Review of Current Trends.

Authors:  Tajudeen O Yahaya; Shemishere B Ufuoma
Journal:  Oman Med J       Date:  2020-05-28

6.  Atypical hyperglycemia presentation suggests considering a diagnostic of other types of diabetes: first reported GCK-MODY in Perú.

Authors:  Juan Carlos Lizarzaburu-Robles; Juan Carlos Gomez-de-la-Torre; María Del Carmen Castro-Mujica; Flor Vento; Sofia Villanes; Elizabeth Salsavilca; Chris Guerin
Journal:  Clin Diabetes Endocrinol       Date:  2020-01-14

7.  Differentiating Among Type 1, Type 2 Diabetes, and MODY: Raising Awareness About the Clinical Implementation of Genetic Testing in Latin America.

Authors:  Lam-Chung César Ernesto; Elizondo Ochoa Álvaro; Segura Kato Yayoi; Silva-Serrano Juanita; Tusié Luna María Teresa; Paloma Almeda-Valdes
Journal:  AACE Clin Case Rep       Date:  2020-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.